China National Medicines Corporation Ltd.

SHSE:600511 주식 보고서

시가총액: CN¥27.3b

China National Medicines 관리

관리 기준 확인 0/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Guotao Tian

최고 경영자

CN¥2.6m

총 보상

CEO 급여 비율n/a
CEO 임기2.5yrs
CEO 소유권n/a
경영진 평균 재임 기간1.9yrs
이사회 평균 재임 기간2.6yrs

최근 관리 업데이트

Recent updates

We Think China National Medicines (SHSE:600511) Can Manage Its Debt With Ease

Nov 12
We Think China National Medicines (SHSE:600511) Can Manage Its Debt With Ease

The China National Medicines Corporation Ltd. (SHSE:600511) Third-Quarter Results Are Out And Analysts Have Published New Forecasts

Oct 25
The China National Medicines Corporation Ltd. (SHSE:600511) Third-Quarter Results Are Out And Analysts Have Published New Forecasts

China National Medicines Corporation Ltd.'s (SHSE:600511) Prospects Need A Boost To Lift Shares

Sep 26
China National Medicines Corporation Ltd.'s (SHSE:600511) Prospects Need A Boost To Lift Shares

Calculating The Fair Value Of China National Medicines Corporation Ltd. (SHSE:600511)

Sep 10
Calculating The Fair Value Of China National Medicines Corporation Ltd. (SHSE:600511)

Returns On Capital At China National Medicines (SHSE:600511) Paint A Concerning Picture

Jul 28
Returns On Capital At China National Medicines (SHSE:600511) Paint A Concerning Picture

China National Medicines Corporation Ltd.'s (SHSE:600511) Low P/E No Reason For Excitement

Jun 24
China National Medicines Corporation Ltd.'s (SHSE:600511) Low P/E No Reason For Excitement

China National Medicines (SHSE:600511) Has Announced That It Will Be Increasing Its Dividend To CN¥0.854

Jun 07
China National Medicines (SHSE:600511) Has Announced That It Will Be Increasing Its Dividend To CN¥0.854

Is China National Medicines (SHSE:600511) Using Too Much Debt?

Jun 05
Is China National Medicines (SHSE:600511) Using Too Much Debt?

Calculating The Fair Value Of China National Medicines Corporation Ltd. (SHSE:600511)

May 21
Calculating The Fair Value Of China National Medicines Corporation Ltd. (SHSE:600511)

Capital Allocation Trends At China National Medicines (SHSE:600511) Aren't Ideal

Apr 10
Capital Allocation Trends At China National Medicines (SHSE:600511) Aren't Ideal

China National Medicines (SHSE:600511) Could Easily Take On More Debt

Feb 28
China National Medicines (SHSE:600511) Could Easily Take On More Debt

CEO

Guotao Tian (53 yo)

2.5yrs

테뉴어

CN¥2,550,000

보상

Mr. Guotao Tian is GM & Director of China National Medicines Corporation Ltd. from April 07, 2022.


리더십 팀

이름위치테뉴어보상소유권
Guotao Tian
GM & Director2.5yrsCN¥2.55m데이터 없음
Fei Chen
Chief Financial Officer1.1yrsCN¥191.30k데이터 없음
Lichun Luo
Board Secretary2.5yrsCN¥1.15m데이터 없음
Zhang Ting
Deputy Secretary of the Party Committeeno dataCN¥371.90k데이터 없음

1.9yrs

평균 재임 기간

46yo

평균 연령

경험이 풍부한 관리: 600511 의 관리팀은 경험 (평균 재직 기간 1.9 년)으로 간주되지 않으므로 새로운 팀을 추천합니다.


이사회 구성원

이름위치테뉴어보상소유권
Guotao Tian
GM & Director2.6yrsCN¥2.55m데이터 없음
Xiuchang Jiang
Chairman13.7yrs데이터 없음데이터 없음
Yong Liu
Director12.9yrs데이터 없음데이터 없음
Jingyun Liu
Chairman of the Supervisory Board12.9yrs데이터 없음데이터 없음
Luwen Shi
Independent Director2.6yrsCN¥200.00k데이터 없음
Xingxi Yu
Independent Director2.6yrsCN¥200.00k데이터 없음
Deyong Wen
Director5.5yrs데이터 없음데이터 없음
Xin Jiang
Director2.6yrsCN¥2.55m데이터 없음
Xiaojuan Li
Director2.6yrs데이터 없음데이터 없음
Kai Lu
Supervisor2.6yrs데이터 없음데이터 없음

2.6yrs

평균 재임 기간

53yo

평균 연령

경험이 풍부한 이사회: 600511 의 이사회경험(평균 재직 기간 2.6 년)으로 간주되지 않으므로 새 이사회가 필요합니다.